The official journal of the Brazilian Retina and Vitreous Society
Fusion proteins for treatment of retinal diseases: aflibercept, ziv-aflibercept, and conbercept
In the last few years, monoclonal antibodies have revolutionized the treatment of retinal neovascular diseases. More recently, a different class of drugs, fusion proteins, has provided an alternative treatment...
Citation: International Journal of Retina and Vitreous 2016 2:3